Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00137644 · ClinicalTrials.gov registry record · Phase 1

Evaluation of the Preventing AIDS Through Live Movement and Sound (PALMS) Intervention for Minority Adolescents

A Phase 1 study, sponsored by Centers for Disease Control and Prevention.

Completed
Registry status
Phase 1
Development phase
264
Enrollment target

NCT00137644: Completed Phase 1 study, sponsored by Centers for Disease Control and Prevention.

NCT00137644 is a Phase 1 study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 264 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (340% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00137644, a Phase 1 study, has completed, sponsored by Centers for Disease Control and Prevention.

COMPLETED
Registry status
Phase 1
Development phase
264 participants
Enrollment target

Study Summary

The purpose of this program evaluation is to determine whether the Preventing AIDS Through Live Movement and Sound (PALMS) group-level intervention is effective in reducing HIV sex risk behaviors and increasing HIV testing of high-risk, incarcerated or adjudicated youth. The intent of this program is to support the evaluation of an existing intervention and provide feedback to the implementing organization for improved program effectiveness, not to conduct research.

Interventions

  • BEHAVIORAL Preventing AIDS Through Live Movement and Sound (PALMS)

Trial Details

FieldValue
Enrollment Target 264 participants
Start Date 2005-03
Est. Completion 2007-01
Phase Phase 1

What the finished NCT00137644 record still lists

NCT00137644 is an interventional study that assigns participants to a tested intervention. The registered 264 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (340% higher).

The record links to 0 conditions, and to 1 intervention - of which Preventing AIDS Through Live Movement and Sound (PALMS) is the first listed.

NCT00137644 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00137644 about?

NCT00137644 is a clinical study titled "Evaluation of the Preventing AIDS Through Live Movement and Sound (PALMS) Intervention for Minority Adolescents". The purpose of this program evaluation is to determine whether the Preventing AIDS Through Live Movement and Sound (PALMS) group-level intervention is effective in reducing HIV sex risk behaviors and increasing HIV testing of high-risk, incarcerated or adjudicated youth. The intent of this program i...

What is the current status of trial NCT00137644?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 264 participants. The study started on 2005-03. Estimated completion is 2007-01.

What interventions are being tested in trial NCT00137644?

The interventions under investigation include: Preventing AIDS Through Live Movement and Sound (PALMS) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00137644?

This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00137644's enrollment target sits among peer trials

264 157th of 2000 higher than 1,843 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04101669 · 264 participants · NA

    RESET System Pivotal Trial (Rev F)

  • NCT04295863 · 264 participants · Phase 1

    Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers

  • NCT05220202 · 264 participants · NA

    MOTIVATE to Improve Outcomes for Older Veterans With Musculoskeletal Pain and Depression

  • NCT05473013 · 264 participants · NA

    Optimizing Digital Health Technology Interventions to Increase Skill Acquisition and Utilization

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00137644, the US trial registry maintained by the National Library of Medicine. NCT00137644 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.